Dow Up 1.30% Nasdaq Up 0.37%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
7.55 Down 0.05(0.66%) Oct 30, 4:00PM EDT
Prev Close:7.60
Open:7.54
Bid:6.54 x 800
Ask:8.23 x 2000
1y Target Est:15.80
Beta:-0.520
Next Earnings Date:N/A
Day's Range:7.39 - 7.66
52wk Range:5.06 - 15.67
Volume:100,315
Avg Vol (3m):278,660
Market Cap:116.90M
P/E (ttm):N/A
EPS (ttm):-1.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CNATDown 0.66%116.90M
GALTUp 3.22%120.13M
ICPTUp 2.56%5.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.62
Quarterly EPS Est (Sep-14) :-0.44
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-4.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback